ZOIA CHIARA PAOLA

Pozzi, F., Conti, E., Remoli, G., Dell'Orto, N., Andreoni, S., Da Re, F., et al. (2025). Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study. JPAD, 12(2) [10.1016/j.tjpad.2024.100027]. Dettaglio

Sala, G., Cuffaro, L., Pozzi, F., Andreoni, S., Bazzini, C., Conti, E., et al. (2025). Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network). FRONTIERS IN AGING NEUROSCIENCE, 17 [10.3389/fnagi.2025.1581892]. Dettaglio

de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I., et al. (2023). Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) [Altro] [10.1038/s41467-023-36192-x]. Dettaglio

Valente, A., Mariani, J., Seminara, S., Tettamanti, M., Pignataro, G., Perego, C., et al. (2023). Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 43(7), 1077-1088 [10.1177/0271678X231159958]. Dettaglio

Saresella, M., Zoia, C., La Rosa, F., Bazzini, C., Sala, G., Grassenis, E., et al. (2023). Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation. PHARMACEUTICALS, 16(12) [10.3390/ph16121725]. Dettaglio